Clinical Trial

Disease: Relapsed or Refractory Non-Hodgkin Lymphoma, NHL, (NCT03939026)

Disease info:

Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. NHL is a term that's used for many different types of lymphoma that all share some of the same characteristics. NHL usually starts in lymph nodes or other lymph tissue, but it can sometimes affect the skin. 

Non-Hodgkin lymphoma is one of the most common cancers in the United States, accounting for about 4% of all cancers. 

Relapsed refers to when a patient has received active treatment, went off treatment and then the disease came back, whereas refractory refers to disease that is progressing despite active treatment.

Indicator
IND Enabling Pre-clinical
Phase I Safety
Phase II Safety and Dosing
Phase III Safety and Efficacy
Feb. 25, 2025

Unlock Premium CMN Content Today with a CMN+ Subscription

Already a CMN+ subscriber? Log in here

logo
Subscribe now

Subscribe to CMN+ and get access to premium CMN Content, CRISPRMED Recordings, Clinical Trial Database, Special offers ....

close
Search CRISPR Medicine